NasdaqGS - Delayed Quote USD
Black Diamond Therapeutics, Inc. (BDTX)
1.9500
+0.0200
+(1.04%)
At close: May 16 at 4:00:01 PM EDT
1.9100
-0.04
(-2.05%)
After hours: May 16 at 7:49:31 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -0.22 | -0.22 | 0.31 | -0.75 |
| Low Estimate | -0.24 | -0.24 | 0.24 | -0.8 |
| High Estimate | -0.21 | -0.21 | 0.38 | -0.71 |
| Year Ago EPS | -0.36 | -0.28 | -1.27 | 0.31 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 3 | 3 |
| Avg. Estimate | -- | -- | 70M | -- |
| Low Estimate | -- | -- | 70M | -- |
| High Estimate | -- | -- | 70M | -- |
| Year Ago Sales | -- | -- | -- | 70M |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | -100.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.39 | -0.36 | -0.31 | -0.25 |
| EPS Actual | -0.36 | -0.28 | -0.28 | 0.98 |
| Difference | 0.03 | 0.08 | 0.03 | 1.23 |
| Surprise % | 6.74% | 21.50% | 10.16% | 484.31% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.22 | -0.22 | 0.31 | -0.75 |
| 7 Days Ago | -0.25 | -0.25 | -0.41 | -0.82 |
| 30 Days Ago | -0.25 | -0.25 | -0.41 | -0.82 |
| 60 Days Ago | -0.25 | -0.25 | -0.92 | -1.02 |
| 90 Days Ago | -0.34 | -0.37 | -1.25 | -1.44 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 2 | -- |
| Up Last 30 Days | 2 | 2 | 5 | 3 |
| Down Last 7 Days | 2 | 2 | -- | 1 |
| Down Last 30 Days | 2 | 2 | 1 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| BDTX | 37.50% | 19.64% | 124.41% | -343.55% |
| S&P 500 | 13.21% | 2.76% | 7.83% | 13.78% |
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/18/2025 |
| Maintains | Stifel: Buy to Buy | 3/7/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/6/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 10/9/2024 |
| Reiterates | Wedbush: Outperform to Outperform | 10/8/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 9/24/2024 |
Related Tickers
XLO Xilio Therapeutics, Inc.
0.8594
+7.42%
INMB INmune Bio, Inc.
7.86
+7.82%
CABA Cabaletta Bio, Inc.
2.0300
+12.15%
KTTA Pasithea Therapeutics Corp.
0.9560
+11.09%
ABP Abpro Holdings, Inc.
0.2300
-13.24%
CTMX CytomX Therapeutics, Inc.
2.0300
+1.50%
CRVS Corvus Pharmaceuticals, Inc.
3.6100
+0.84%
ENSC Ensysce Biosciences, Inc.
2.3400
+9.35%
CNSP CNS Pharmaceuticals, Inc.
1.2800
+1.59%
NCNA NuCana plc
0.0438
-17.98%